EDGAR Filing Documents for 0001140361-19-012961

Form 8-K - Current report:

SEC Accession No. 0001140361-19-012961

Filing Date

2019-07-16

Accepted

2019-07-15 18:11:06

Documents

Period of Report

2019-07-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	form8k.htm	8-K	42043
2	EXHIBIT 4.1	ex4_1.htm	EX-4.1	920553
3	EXHIBIT 4.2	ex4_2.htm	EX-4.2	150210
4	EXHIBIT 10.1	ex10_1.htm	EX-10.1	257813
5	EXHIBIT 10.2	ex10_2.htm	EX-10.2	301594
6	EXHIBIT 99.1	ex99_1.htm	EX-99.1	13696
7		image00001.jpg	GRAPHIC	1808
8		image_ex99-1.jpg	GRAPHIC	2164
	Complete submission text file	0001140361-19-012961.txt		1693097

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059

Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900

Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)